499 related articles for article (PubMed ID: 14668111)
41. Response of pepper plants (Capsicum annum L.) on soil amendment by inorganic and organic compounds of arsenic.
Száková J; Tlustos P; Goessler W; Pavlíková D; Schmeisser E
Arch Environ Contam Toxicol; 2007 Jan; 52(1):38-46. PubMed ID: 17031752
[TBL] [Abstract][Full Text] [Related]
42. A human PBPK/PD model to assess arsenic exposure risk through farmed tilapia consumption.
Ling MP; Liao CM
Bull Environ Contam Toxicol; 2009 Jul; 83(1):108-14. PubMed ID: 19452117
[TBL] [Abstract][Full Text] [Related]
43. Inorganic arsenic compounds and methylated metabolites induce morphological transformation in two-stage BALB/c 3T3 cell assay and inhibit metabolic cooperation in V79 cell assay.
Tsuchiya T; Tanaka-Kagawa T; Jinno H; Tokunaga H; Sakimoto K; Ando M; Umeda M
Toxicol Sci; 2005 Apr; 84(2):344-51. PubMed ID: 15647599
[TBL] [Abstract][Full Text] [Related]
44. Time course of urothelial changes in rats and mice orally administered arsenite.
Arnold LL; Suzuki S; Yokohira M; Kakiuchi-Kiyota S; Pennington KL; Cohen SM
Toxicol Pathol; 2014 Jul; 42(5):855-62. PubMed ID: 23690446
[TBL] [Abstract][Full Text] [Related]
45. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
[TBL] [Abstract][Full Text] [Related]
46. A physiologically based pharmacokinetic model of inorganic arsenic.
Yu D
Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):128-41. PubMed ID: 10341143
[TBL] [Abstract][Full Text] [Related]
47. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
Waalkes MP; Liu J; Ward JM; Diwan BA
Toxicol Appl Pharmacol; 2004 Aug; 198(3):377-84. PubMed ID: 15276417
[TBL] [Abstract][Full Text] [Related]
48. Urinary arsenic speciation and porphyrins in C57Bl/6J mice chronically exposed to low doses of sodium arsenate.
Wu H; Manonmanii K; Lam PK; Huang SH; Wang JP; Ng JC
Toxicol Lett; 2004 Dec; 154(1-2):149-57. PubMed ID: 15475189
[TBL] [Abstract][Full Text] [Related]
49. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
[TBL] [Abstract][Full Text] [Related]
50. Effects of exogenous GSH and methionine on methylation of inorganic arsenic in mice exposed to arsenite through drinking water.
Jin Y; Zhao F; Zhong Y; Yu X; Sun D; Liao Y; Lv X; Li G; Sun G
Environ Toxicol; 2010 Aug; 25(4):361-6. PubMed ID: 19449390
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations.
El-Masri HA; Hong T; Henning C; Mendez W; Hudgens EE; Thomas DJ; Lee JS
Environ Health Perspect; 2018 Jul; 126(7):077004. PubMed ID: 30024383
[TBL] [Abstract][Full Text] [Related]
52. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico.
Meza MM; Kopplin MJ; Burgess JL; Gandolfi AJ
Environ Res; 2004 Oct; 96(2):119-26. PubMed ID: 15325872
[TBL] [Abstract][Full Text] [Related]
53. Dynamical coupling of PBPK/PD and AUC-based toxicity models for arsenic in tilapia Oreochromis mossambicus from blackfoot disease area in Taiwan.
Liao CM; Liang HM; Chen BC; Singh S; Tsai JW; Chou YH; Lin WT
Environ Pollut; 2005 May; 135(2):221-33. PubMed ID: 15734582
[TBL] [Abstract][Full Text] [Related]
54. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
55. Urinary arsenic speciation profiles in mice subchronically exposed to low concentrations of sodium arsenate in drinking water.
Wu H; Krishnamohan M; Lam PK; Ng JC
Kaohsiung J Med Sci; 2011 Sep; 27(9):417-23. PubMed ID: 21914530
[TBL] [Abstract][Full Text] [Related]
56. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate.
Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Razo LM; Thomas DJ
Toxicol Appl Pharmacol; 2003 Sep; 191(3):202-10. PubMed ID: 13678653
[TBL] [Abstract][Full Text] [Related]
57. [Distribution of arsenic species and its DNA damage in subchronic arsenite-exposed mice].
Li H; Lin J; Li Y; Yan J; Li B; Zhang W; Dong Z; Chen C
Wei Sheng Yan Jiu; 2013 Sep; 42(5):764-9, 776. PubMed ID: 24218882
[TBL] [Abstract][Full Text] [Related]
58. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
59. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
[TBL] [Abstract][Full Text] [Related]
60. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
